Lincoln Pharmaceuticals Limited (LINCOLN.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹549.75 (+4.37%) as of
Key statistics
- Market cap
- 11.01B
- P/E (TTM)
- 11.42
- EPS (TTM)
- 48.16
- Dividend yield
- 0.34%
- 52-week range
- 439.95 – 770.00
- Beta
- 0.47
- Revenue (TTM)
- 6.94B
- Profit margin
- 13.89%
- Volume
- 4.93k
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, anti-infective, anti-bacterial, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics in the form of tablets, capsules, injectables, dry syrups, sprays, ointments etc. It exports its products to Europe, Canada, Latin and North America, Africa, Asia, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ahmedabad, India
- Employees
- 1,352
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.